A novel NF-κB inhibitor, IT-901, induces significant cell apoptosis in primary RT cells and RT-PDX models by downregulating the expression of the anti-apoptotic protein XIAP and upregulating the pro-apoptotic protein Bim in tumor cells [79]. Here, NFKB1 is linked to neoplasm.